Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2009.505 | A double-blinded, randomized controlled trial to investigate the effects of Transcuaneous acupoint electrical stimulation (TAES) on postoperative pain management for patients undergoing open heart surgery | Ms. Law Wan Sze |
| 2014.574 | A double-blinded, randomized controlled trial on depot medroxyprogesterone acetate (DMPA) and GnRH analogue in pre-menopausal women suffered from uterine fibroid | Dr. LAW Sze Man |
| 2022.185 | A double-blinded, randomised controlled trial to investigate the treatment effects of pulsed electromagnetic field (PEMF) on end stage of Knee Osteoarthritis |
Prof. ONG Michael Tim Yun 王添欣 |
| 2007.085 | A Double-blinded and Randomized Study to Compare the Efficacy and Safety of 48-Week Treatment with Clevudine 30 mg qd Versus Lamivudine 100 mg qd for Chronic Hepatitis B Infection | Dr. Hui Josun Aric |
| 2024.058 | A Double-Blind, Randomized, Placebo-Controlled, Single and Multiple Dose Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AB-101, an Oral PD-L1 Inhibitor, in Healthy Subjects and Subjects with Chronic HBV Infection | Prof. WONG Grace Lai Hung |
| 2018.313 | A Double-Blind, Randomized, Placebo-Controlled, Single and Multiple Dose Study Evaluating the Safety, Tolerability, and Pharmacokinetics of AB-506, an HBV Capsid Inhibitor, in Healthy Subjects and HBV-DNA Positive Subjects with Chronic HBV Infection |
Prof. CHAN Henry Lik Yuen 陳力元 |
| 2004.412 | A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SB-497115-GR, A Thrombopoietin Receptor Agonist, Administered at 30, 50 and 75 mg as Oral Tablets Once-Daily for 6 Weeks to Adult Male and Female Subjects with Refractory, Chronic Immune Thrombocytopenic Purpura | Prof. Cheng Gregory |
| 2011.271 | A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate Tolerablility and Efficacy of AMG 145 on LDL-C in Subjects with Heterozygous Familial Hypercholesterolemia | Professor Tomlinson Brian |
| 2012.269 | A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate Safety, Tolerability and Efficacy of AMG 145 on LDL-C in Subjects with Heterozygous Familial Hypercholesterolemia | Professor Tomlinson Brian |
| 2009.531 | A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects with Symptomatic Left Ventricular Systolic Dysfunction and Anemia | Prof. Yan Bryan Ping Yen |
| 2022.449 | A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Olpasiran on Major Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein (a) |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2012.331 | A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Additional LDL-Cholesterol Reduction on Major Cardiovascular Events When AMG 145 is Used in Combination With Statin Therapy In Patients with Clinically Evident Cardiovascular Disease | Professor Tomlinson Brian |
| 2025.311 | A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing Olpasiran Use to Prevent First Major Cardiovascular Events in Participants with Elevated Lipoprotein(a) |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2024.330 | A double-blind, randomized, placebo-controlled trial to evaluate the efficacy, pharmacokinetics and safety of remibrutinib (LOU064) for 24 weeks in adolescents from 12 to less than 18 years of age with chronic spontaneous urticaria inadequately controlled by H1-antihistamines followed by an optional open-label extension for up to another 3 years and an optional safety long-term treatment-free follow-up period for up to an additional 3 years |
Prof. LEUNG Ting Fan 梁廷勳 |
| 2015.575 | A Double-blind, Randomized, Placebo-Controlled Trial of Curcumin versus Placebo for Prevention of Relapse in Patients with Ulcerative Colitis |
Prof. NG Siew Chien 黃秀娟 |
| 2013.493 | A Double-blind, Randomized, Placebo-Controlled Study Evaluating the Safety and Effectiveness of Cook MyoSite Incorporated AMDC in Female Patients with Stress Urinary Incontinence | Prof Ng Chi Fai |
| 2007.246 | A Double-Blind, Randomized, Placebo-Controlled Phase III Study to Assess the Efficacy of recMAGE-A3 + AS15 Antigen Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients with Resectable MAGE-A3-Positive Non-Small Cell Lung Cancer | Prof. MOK Tony SK |
| 2008.317 | A Double-Blind, Randomized, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Satavaptan (SR121463B) versus Placebo in Patients with Dilutional Hyponatremia due to the Syndrome of Inappropriate Antidiuretic Hormone Sescretion (SIADH) | Prof. Wong Kwok Chu |
| 2007.486 | A Double-blind, Randomized, Placebo-control Trial to Assess the Effects of Hydroxychloroquine on Progression of Carotid Artery Intimal-Medial Thickening in Psoriatic Arthritis | Ms Tam Lai Shan |
| 2010.583 | A double-blind, randomized, placebo controlled trial of misoprostol for healing of small bowel ulcers in aspirin users with small bowel bleeding (MISO-SB Study) | Prof. CHAN Ka Leung |
| 2012.273 | A Double-blind, Randomized, Placebo and Ezetimibe Controlled, Multicenter Study to Evaluate Safety, Tolerability and Efficacy of AMG 145 on LDL-C in Combination With Statin Therapy in Subjects With Primary Hypercholesterolemia and Mixed Dyslipidemia | Dr Ozaki Risa |
| 2007.501 | A Double-blind, Randomized, Multicenter, Phase III Study of Bevacizumab in Combination with Capecitabine and Cisplatin Versus Placebo in Combination with Capecitabine and Cisplatin, as First-line Therapy in Patients with Advanced Gastric Cancer | Dr Lam Kwok Chi |
| 2012.276 | A Double-blind, Randomized, Multicenter Study to Evaluate Safety and Efficacy of AMG 145, Compared With Ezetimibe, in Hypercholesterolemic Subjects Unable to Tolerate an Effective Dose of a HMG-CoA Reductase Inhibitor | Professor Tomlinson Brian |
| 2010.111 | A Double-Blind, Randomized, Multicenter Efficacy and Safety of Pregabalin (Lyrica) as Monotherapy in Patients with Partial Seizures | Prof. Kwan Patrick |
| 2018.223 | A Double-blind, Randomized, Active-controlled, Parallel-group Study of Paliperidone Palmitate 6-Month Formulation |
Prof. CHAN Sandra Sau Man 陳秀雯 |
| 2024.093 | A Double-Blind, Randomised, Placebo-Controlled, Multicentre Study Evaluating the Efficacy and Safety of Baxdrostat in Participants with Uncontrolled Hypertension on Two or More Medications including Participants with Resistant Hypertension (BaxAsia) |
Prof. TAN Guangming 譚廣明 |
| 2016.359 | A double-blind, randomised, placebo-controlled trial evaluating the effect of BI 655064 administered as sub-cutaneous injections, on renal response after one year of treatment, in patients with active lupus nephritis |
Prof. TAM Lai Shan 譚麗珊教授 |
| 2014.440 | A double-blind, randomised, placebo controlled Phase III study of nintedanib plus best supportive care (BSC) versus placebo plus BSC in patients with colorectal cancer refractory to standard therapies. | Prof. MA Brigette |
| 2010.053 | A double-blind, placebo-controlled, randomized, multicenter study to investigate CHInese Medicine Neuroaid Efficacy on Stroke recovery | Prof. Wong Lawrence K.S. |
| 2005.358 | A Double-Blind, Placebo-Controlled, Multicenter Phase IIb Extension Study to Evaluate the Safety and Efficacy of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects | Prof. Gin Tony |
| 2008.250 | A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects with Refractory Partial Seizures | Dr Kwan Patrick |
| 2013.504 | A double-blind, placebo-controlled study of N-acetylcysteine for ketamine dependence | Prof Tang Wai Kwong |
| 2003.114 | A Double-Blind, Placebo Controlled, Parallel Group Study of the Effects of Zoniporide on Perioperative Cardiac Events in High Risk Subjects Undergoing Non-Cardiac Vascular Surgery | Prof. Lau Yun Wong James |
| 2010.265 | A double-blind, parallel group placebo-controlled study of Prazosin for recurrent nightmares in patients with major depressive disorder | Prof. Wing Yun Kwok |
| 2001.507 | A Double-blind, Multicenter, Placebo- and Active-controlled Acute and Extension Study of 2 Doses of MK-0869 in the Treatment of Patients with Major Depressive Disorder | Dr. Chan Sau Man Sandra |
| 2002.462 | A Double-Blind Randomized Placebo-Controlled Clinical Trial of Chinese Herbal Medicine in Treatment of Advanced Non-Small Cell Lung Cancer | Prof. Mok Tony |
| 2001.287 | A Double-blind Randomized Placebo-control Clinical Trial of Chinese Herbal Medicine in Treatment of Advanced Non-Small Cell Lung Cancer | MOK SK Tony |
| 2008.405 | A Double-Blind Randomized Placebo Controlled Trial of Rabeprazole for Prevention of NSAID Associated Dyspepsia and Gastroduodenal Injury (RAN Study) | Prof Chan Francis KL |
| 2010.181 | A double-blind randomized controlled trial on whole soy and daidzein supplementation on reduction of blood pressure in prehypertensive postmenopausal Chinese women | Prof. Ho Suzanne Sutying |
| 2005.153 | A double-blind randomized comparison of celecoxib plus esomeprazole versus naproxen plus esomeprazole for prevention of recurrent ulcer bleeding in patients with arthritis and cardiothrombotic diseases (NSAID#8 Study) | Prof. CHAN Francis K. L. |
| 2002.310 | A Double-blind Randomized Comparison of Celecoxib Plus Esomeprazole Versus Celecoxib for the Prevention of Recurrent Ulcer Bleeding in Arthritis Patients (NSAID#7 Study) | Prof. Chan Ka Leung Francis |
| 2004.295 | A Double-Blind Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of A 72-Hour Infusion of CP-101,606 in Subjects with Acute Ischemic Stroke | Prof. Wong Ka Sing Lawrence |
| 2002.068 | A Double Blinded, Randomized, Placebo Controlled Trial of Co-Therapy of Aspirin with Esomeprazole Versus Clopidogrel for the Secondary Prevention of Upper Gastrointestinal Bleeding in Patients with Ischemic Heart Disease or Stroke (NSAID#6 study) | Prof. Chan Ka Leung Francis |
| 2021.381 | A double blinded randomized controlled trial on prophylactic clipping to prevent post-polypectomy bleeding after colonoscopy in direct oral anticoagulant users | Dr. LAU Louis Ho Shing |
| 2025.133 | A Dose-Finding, Adaptive, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Efficacy of TAK-360 in Participants with Idiopathic Hypersomnia (IH) | Prof. WING Yun Kwok |
| 2014.082 | A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects with Lupus Nephritis | Prof. TAM Lai Shan |
| 2026.393 | A Digital School-based Nutrition and Lifestyle Intervention to Improve Bone-health Knowledge and Behaviours in Early Adolescents | Dr. Lau Adam Yiu Chung |
| 2017.248 | A different level of single-dose and multiple-dose study to evaluate the pharmacokinetics of ranolazine in a Chinese population |
Dr. LUK Andrea On Yan 陸安欣 |
| 2018.093 | A different level of single-dose and multiple-dose study to evaluate the pharmacokinetics of Bilastine in a Chinese population |
Dr. LUK Andrea On Yan 陸安欣 |
| 2010.428 | A development study on lexical tone dichotic listening in children: Identifying Cantonese-speaking children with auditory processing disorder (APD) | Prof Kam Chi Shan |
Page 281 of 288.